Marked elevation of creatine phosphokinase alone caused by sintilimab - beware of hypothyroid myopathy

Eur J Cancer. 2020 Mar:128:57-59. doi: 10.1016/j.ejca.2019.12.030. Epub 2020 Mar 5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma of Lung / blood
  • Adenocarcinoma of Lung / drug therapy
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Asymptomatic Diseases / therapy
  • Creatine Kinase / blood*
  • Humans
  • Hypothyroidism / blood
  • Hypothyroidism / chemically induced*
  • Hypothyroidism / diagnosis
  • Hypothyroidism / drug therapy
  • Lung Neoplasms / blood
  • Lung Neoplasms / drug therapy
  • Male
  • Middle Aged
  • Muscular Diseases / blood
  • Muscular Diseases / chemically induced*
  • Muscular Diseases / diagnosis
  • Muscular Diseases / drug therapy
  • Paclitaxel / adverse effects
  • Thyroxine / administration & dosage

Substances

  • Antibodies, Monoclonal, Humanized
  • sintilimab
  • Creatine Kinase
  • Paclitaxel
  • Thyroxine